科伦博泰生物-B:收到根据与WINDWARD BIO AG关于SKB378/HBM9378/WIN378的许可协议以现金及股权支付的首付款

格隆汇
23 May

格隆汇5月23日丨科伦博泰生物-B(06990.HK)宣布,根据该公告披露之许可协议条款,公司已自Windward Bio收到首付款,包括:(i)现金付款,该款项于2025年2月收到,及(ii)Windward Bio母公司的股权,该股权于获得中国境内相关监管批准并满足其他交割条件后在2025年5月完成交割。SKB378/HBM9378/WIN378是公司与和铂医药共同开发的项目,双方平分全球权利...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10